![Challenges in early detection of HCC Prof Simone Strasser Prof Simone Strasser](https://clinicalvalue.com/wp-content/uploads/2024/06/Prof-Simone-Strasser.png)
Recent Articles
![Challenges in early detection of HCC Prof Simone Strasser Prof Simone Strasser](https://clinicalvalue.com/wp-content/uploads/2024/06/Prof-Simone-Strasser.png)
![Advancements, challenges, and strategies surrounding HCC surveillance HCC Full Video HCC Full Video](https://clinicalvalue.com/wp-content/uploads/2024/06/HCC-Full-Video.png)
Advancements, challenges, and strategies surrounding HCC surveillance
![The implications of identifying and managing HCC surveillance patients in General Practice Carrin Cheung Carrin Cheung](https://clinicalvalue.com/wp-content/uploads/2024/06/Carrin-Cheung.png)
The implications of identifying and managing HCC surveillance patients in General Practice
![Hepatocellular Carcinoma Surveillance: Challenging the status quo Hepatocellular Hepatocellular](https://clinicalvalue.com/wp-content/uploads/2024/06/Hepatocellular.png)
Hepatocellular Carcinoma Surveillance: Challenging the status quo
![Empowering Healthcare Professionals to Combat Liver Cancer in Australia About HCC About HCC](https://clinicalvalue.com/wp-content/uploads/2024/06/About-HCC-1280x853.png)
![HCC resources for healthcare professionals AdobeStock 393607469 AdobeStock 393607469](https://clinicalvalue.com/wp-content/uploads/2024/05/AdobeStock_393607469-1280x720.jpg)
![Research Spotlight Roche 114371 Roche 114371](https://clinicalvalue.com/wp-content/uploads/2024/05/Roche_114371-1280x720.png)
![Unravelling the enigma: Metabolic associated fatty liver disease (MAFLD) and liver cancer AdobeStock 315999280 AdobeStock 315999280](https://clinicalvalue.com/wp-content/uploads/2024/05/AdobeStock_315999280-1280x853.jpg)
Unravelling the enigma: Metabolic associated fatty liver disease (MAFLD) and liver cancer
![Who should be tested for liver cancer and why is testing so important? AdobeStock 316144458 AdobeStock 316144458](https://clinicalvalue.com/wp-content/uploads/2024/05/AdobeStock_316144458-1280x853.jpeg)
Who should be tested for liver cancer and why is testing so important?
![The epidemiology of liver cancer in Australia HCC Epidemiology HCC Epidemiology](https://clinicalvalue.com/wp-content/uploads/2024/05/HCC-Epidemiology-1280x928.jpeg)
![Liver cancer surveillance: what’s stopping my patients getting tested? Health Test Health Test](https://clinicalvalue.com/wp-content/uploads/2024/05/Health-Test-1280x916.jpeg)
Liver cancer surveillance: what’s stopping my patients getting tested?
![Hepatocellular Carcinoma Clinical Practice Guidelines Roche 10339 Roche 10339](https://clinicalvalue.com/wp-content/uploads/2024/04/Roche_10339-1280x720.png)
![Looking to the Future – Blood-based Biomarkers for Liver Cancer Surveillance reasearch on HCC reasearch on HCC](https://clinicalvalue.com/wp-content/uploads/2024/02/reasearch-on-HCC-1280x720.jpg)
Looking to the Future – Blood-based Biomarkers for Liver Cancer Surveillance
![HCC Resources for Patients and Their Families AdobeStock 367289163 Woman putting on a head scarf while looking in the mirror standing in home interior, alopecia and cancer awareness.](https://clinicalvalue.com/wp-content/uploads/2024/02/AdobeStock_367289163.jpg)
![HCC Monitoring and Surveillance Update - The Limbic HCC monitoring and surveillance udpate HCC monitoring and surveillance udpate](https://clinicalvalue.com/wp-content/uploads/2023/11/HCC-monitoring-and-surveillance-udpate-1280x715.png)
![Patient-centric and ecosystem insights into hepatocellular carcinoma across Asia-Pacific - LEAP Screenshot 2023 10 02 100520 Screenshot 2023 10 02 100520](https://clinicalvalue.com/wp-content/uploads/2023/10/Screenshot-2023-10-02-100520.jpg)
Patient-centric and ecosystem insights into hepatocellular carcinoma across Asia-Pacific – LEAP
In this white paper, insights on the liver ecosystem are uncovered, with the intention of facilitating action among various stakeholders to reduce liver cancer incidence and…
READ MORE![Building modern hepatocellular carcinoma surveillance programmes: taking steps to address a leading cause of liver cancer death in Asia roche roche](https://clinicalvalue.com/wp-content/uploads/2023/08/roche-hcc_hero_1920x450px.jpg)
Building modern hepatocellular carcinoma surveillance programmes: taking steps to address a leading cause of liver cancer death in Asia
In this whitepaper, HCC surveillance programs in Asia were analysed. The learnings from well established HCC surveillance programs, as well as the challenges in areas that…
READ MORE![International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma Untitled presentation Untitled presentation](https://clinicalvalue.com/wp-content/uploads/2023/03/Untitled-presentation.png)
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
This white paper, which was developed by a group of experts in biomarker development, provides a framework on best practices to design, execute, and interpret biomarker…
READ MORE![Liver Disease in Asia Pacific: Insights from Prof Pierce Chow Liver Disease in Asia Pacific Insights from Prof Pierce Chow Liver Disease in Asia Pacific Insights from Prof Pierce Chow](https://clinicalvalue.com/wp-content/uploads/2022/12/Liver-Disease-in-Asia-Pacific_-Insights-from-Prof-Pierce-Chow.jpg)
Liver Disease in Asia Pacific: Insights from Prof Pierce Chow
In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical…
READ MORE![Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance Liver Cancer in Japan Dr Shun Kaneko on HCC Screening and Surveillance Liver Cancer in Japan Dr Shun Kaneko on HCC Screening and Surveillance](https://clinicalvalue.com/wp-content/uploads/2022/12/Liver-Cancer-in-Japan_-Dr-Shun-Kaneko-on-HCC-Screening-and-Surveillance.jpg)
Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance
Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the…
READ MORE![Strengthening healthcare systems through the critical role of diagnostics Strengthening healthcare systems through the critical role of diagnostics Strengthening healthcare systems through the critical role of diagnostics](https://clinicalvalue.com/wp-content/uploads/2022/12/Strengthening-healthcare-systems-through-the-critical-role-of-diagnostics.jpg)
Strengthening healthcare systems through the critical role of diagnostics
In line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together to…
READ MORE![APACMed White Paper - Strengthening Healthcare Systems Through the Critical Role of Diagnostics APACMed White Paper Strengthening Healthcare Systems Through the Critical Role of Diagnostics APACMed White Paper Strengthening Healthcare Systems Through the Critical Role of Diagnostics](https://clinicalvalue.com/wp-content/uploads/2022/12/APACMed-White-Paper-Strengthening-Healthcare-Systems-Through-the-Critical-Role-of-Diagnostics_.jpg)
APACMed White Paper – Strengthening Healthcare Systems Through the Critical Role of Diagnostics
Diagnostic technologies are used across the entire patient journey of multiple disease states, and provide the tools to prevent, detect, and monitor the required interventions. Despite…
READ MORE